Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
01 1Farmhispania, S.A.
02 3Chunghwa Chemical Synthesis & Biotech. Ltd
03 1Chunghwa Chemical Sysnthsis & Biotech Co.,Ltd.
04 1Dr. Reddy's Laboratories Limited
05 3Biocon Limited
06 1Biocon limited
07 1BrightGene Bio-Medical Technology Co., Ltd.
08 1CONCORD BIOTECH LTD
09 1MSN Laboratories Private Limited
10 1NATCO PHARMA LIMITED
11 2Novartis Pharmaceuticals Corporation
12 1ScinoPharm Taiwan Ltd.
01 3EVEROLIMUS
02 10Everolimus
03 1Everolimus B02
04 1Everolimus Premix 2 %
05 2everolimus
01 1China
02 8India
03 1Spain
04 2Switzerland
05 5Taiwan
NDC Package Code : 17404-1027
Start Marketing Date : 2019-12-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6234
Start Marketing Date : 2018-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 71796-012
Start Marketing Date : 2020-03-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6247
Start Marketing Date : 2018-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6253
Start Marketing Date : 2018-01-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6270
Start Marketing Date : 2021-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62227-019
Start Marketing Date : 2020-12-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0126
Start Marketing Date : 2024-03-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0078-1182
Start Marketing Date : 2009-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0078-1406
Start Marketing Date : 2009-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Everolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Everolimus, including repackagers and relabelers. The FDA regulates Everolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Everolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Everolimus manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Everolimus supplier is an individual or a company that provides Everolimus active pharmaceutical ingredient (API) or Everolimus finished formulations upon request. The Everolimus suppliers may include Everolimus API manufacturers, exporters, distributors and traders.
click here to find a list of Everolimus suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Everolimus as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Everolimus API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Everolimus as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Everolimus and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Everolimus NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Everolimus suppliers with NDC on PharmaCompass.
We have 10 companies offering Everolimus
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?